{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:09:32Z","timestamp":1774249772969,"version":"3.50.1"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Acta Biochim. Pol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Benign paroxysmal positional vertigo (BPPV) is a common vestibular disorder that responds well to canalith repositioning maneuvers but is frequently complicated by recurrence. Increasing evidence suggests that systemic inflammation may influence disease course and recurrence risk. This study aimed to investigate the association between routinely available systemic inflammatory markers and BPPV recurrence within 6\u00a0months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this single-center retrospective cohort study, 300 adult patients diagnosed with BPPV between January 2020 and December 2024 were included. Neutrophil-to-lymphocyte ratio (NLR), systemic immune-inflammation index (SII), and C-reactive protein (CRP) levels measured at initial presentation were analyzed. Recurrence within 6\u00a0months following successful canalith repositioning maneuvers was defined as the primary outcome. Group comparisons were performed using non-parametric tests. Independent predictors of recurrence were identified using multivariable logistic regression analysis, and receiver operating characteristic (ROC) analysis was used to evaluate discriminatory performance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      During the six-month follow-up period, recurrence occurred in 78 patients (26.0%). Patients with recurrence had significantly higher NLR and CRP levels compared with those without recurrence (both\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). SII values were also elevated in the recurrence group, although the difference was less pronounced (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.048). In multivariable analysis adjusted for age, sex, and canal involvement, both NLR (odds ratio [OR]: 1.42; 95% confidence interval [CI]: 1.18\u20131.71) and CRP (OR: 1.27; 95% CI: 1.10\u20131.46) emerged as independent predictors of BPPV recurrence. ROC analysis demonstrated moderate discriminatory ability for NLR (AUC = 0.71) and CRP (AUC = 0.69), whereas SII showed limited predictive performance (AUC = 0.62).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Systemic inflammatory markers, particularly NLR and CRP, are independently associated with recurrence risk in BPPV. Given their low cost and widespread availability, these markers may provide complementary information for early risk stratification. Further prospective and multicenter studies are required to clarify causal mechanisms and confirm clinical applicability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/abp.2026.16188","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:10:06Z","timestamp":1774246206000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association between systemic inflammatory markers and recurrence risk in benign paroxysmal positional vertigo: a retrospective cohort study"],"prefix":"10.3389","volume":"73","author":[{"given":"Bekir","family":"Do\u011fan","sequence":"first","affiliation":[{"name":"Department of Otorhinolaryngology, Zonguldak Atat\u00fcrk State Hospital","place":["Zonguldak, T\u00fcrkiye"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deniz","family":"Baklac\u0131","sequence":"additional","affiliation":[{"name":"Department of Otorhinolaryngology, Faculty of Medicine, Zonguldak B\u00fclent Ecevit University","place":["Zonguldak, T\u00fcrkiye"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00405-024-09094-x","article-title":"Life after benign paroxysmal positional vertigo: One-year analysis of recurrence, headaches, neck pain, falls, and functional vestibular symptoms","volume":"282","author":"Acle-Cervera","year":"2025","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1595693","DOI":"10.3389\/fneur.2025.1595693","article-title":"Benign paroxysmal positional vertigo: a systematic review of the effects of comorbidities","volume":"16","author":"Alolayet","year":"2025","journal-title":"Front. Neurol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1177\/0194599816689667","article-title":"Clinical practice guideline: benign paroxysmal positional vertigo (update)","volume":"156","author":"Bhattacharyya","year":"2017","journal-title":"Otolaryngol. Head. Neck Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00405-013-2728-4","article-title":"Recurrence of benign paroxysmal positional vertigo: role of inflammation and metabolic factors","volume":"271","author":"De Stefano","year":"2014","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1002\/ijc.32396","article-title":"The systemic immune-inflammation index is associated with an increased risk of incident cancer","volume":"146","author":"Fest","year":"2020","journal-title":"Int. J. Cancer"},{"key":"B7","doi-asserted-by":"publisher","first-page":"CD003162","DOI":"10.1002\/14651858.CD003162.pub3","article-title":"The epley manoeuvre for benign paroxysmal positional vertigo","volume":"12","author":"Hilton","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"8211","DOI":"10.18632\/oncotarget.2363","article-title":"Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma","volume":"5","author":"Hu","year":"2014","journal-title":"Oncotarget"},{"key":"B9","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/MOO.0000000000000483","article-title":"Otolithic degeneration in aging and vestibular disorders","volume":"26","author":"Ishiyama","year":"2018","journal-title":"Curr. Opin. Otolaryngol. Head. Neck Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1056\/NEJMra1309481","article-title":"Benign paroxysmal positional vertigo","volume":"370","author":"Kim","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1515\/cclm-2019-0990","article-title":"Clinical usefulness of inflammatory biomarkers","volume":"58","author":"Lippi","year":"2020","journal-title":"Clin. Chem. Lab. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1735898","DOI":"10.3389\/fneur.2025.1735898","article-title":"Research progress on risk factors of recurrence of benign paroxysmal positional vertigo","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Neurol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1080\/00016489.2019.1597661","article-title":"Neutrophil-to-lymphocyte ratio as a prognostic marker in vestibular disorders","volume":"139","author":"Ozdemir","year":"2019","journal-title":"Acta Otolaryngol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI18921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J. Clin. Invest"},{"key":"B15","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MAO.0b013e3182487f78","article-title":"Recurrence of benign paroxysmal positional vertigo","volume":"33","author":"Perez","year":"2012","journal-title":"Otol. Neurotol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1159\/000381260","article-title":"Low-grade inflammation and benign paroxysmal positional vertigo","volume":"20","author":"Talaat","year":"2015","journal-title":"Audiol. Neurootol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"461","DOI":"10.14639\/0392-100X-N1233","article-title":"Recurrence of benign paroxysmal positional vertigo: experience in 3042 patients","volume":"41","author":"Teggi","year":"2021","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"B4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1212\/01.wnl.0000266620.59840.c0","article-title":"Epidemiology of benign paroxysmal positional vertigo: a population-based study","volume":"69","author":"von Brevern","year":"2007","journal-title":"Neurology"},{"key":"B5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/VES-150553","article-title":"Benign paroxysmal positional vertigo: diagnostic criteria","volume":"25","author":"von Brevern","year":"2015","journal-title":"J. Vestib. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"E140","DOI":"10.1002\/lary.26925","article-title":"Systemic inflammatory markers in benign paroxysmal positional vertigo","volume":"128","author":"Yang","year":"2018","journal-title":"Laryngoscope"},{"key":"B20","first-page":"5","article-title":"Ratio of neutrophil to lymphocyte counts\u2014rapid and simple parameter of systemic inflammation and stress in critically ill","volume":"102","author":"Zahorec","year":"2001","journal-title":"Bratisl. Lek. Listy"}],"container-title":["Acta Biochimica Polonica"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/abp.2026.16188\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T06:10:07Z","timestamp":1774246207000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/abp.2026.16188\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,23]]},"references-count":20,"alternative-id":["10.3389\/abp.2026.16188"],"URL":"https:\/\/doi.org\/10.3389\/abp.2026.16188","relation":{},"ISSN":["1734-154X"],"issn-type":[{"value":"1734-154X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,23]]},"article-number":"16188"}}